Approval · Notice of Compliance 7828 · 2006
RIVA-AZITHROMYCIN: Notice of Compliance 7828
Issued March 15, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7828
- Date
- March 15, 2006
- Company
- Laboratoire Riva Inc.Blainville, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- Antibiotic
- Canadian reference product
- ZITHROMAX (Pfizer Canada Ulc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RIVA-AZITHROMYCIN | 02275309 | Marketed |
| RIVA-AZITHROMYCIN | 02275317 | Cancelled Post Market |
Medicinal ingredients
- AZITHROMYCIN MONOHYDRATE 250 MG per TAB
- AZITHROMYCIN MONOHYDRATE 600 MG per TAB